438 related articles for article (PubMed ID: 15829708)
1. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria.
Yu D; Petermann A; Kunter U; Rong S; Shankland SJ; Floege J
J Am Soc Nephrol; 2005 Jun; 16(6):1733-41. PubMed ID: 15829708
[TBL] [Abstract][Full Text] [Related]
2. Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity.
Petermann A; Floege J
Nephron Clin Pract; 2007; 106(2):c61-6. PubMed ID: 17570931
[TBL] [Abstract][Full Text] [Related]
3. Acute and transient podocyte loss and proteinuria in preeclampsia.
Aita K; Etoh M; Hamada H; Yokoyama C; Takahashi A; Suzuki T; Hara M; Nagata M
Nephron Clin Pract; 2009; 112(2):c65-70. PubMed ID: 19390204
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Xiao H; Shi W; Liu S; Wang W; Zhang B; Zhang Y; Xu L; Liang X; Liang Y
Am J Nephrol; 2009; 30(1):34-43. PubMed ID: 19202327
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
6. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
[TBL] [Abstract][Full Text] [Related]
7. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
8. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.
Hara M; Yanagihara T; Kihara I; Higashi K; Fujimoto K; Kajita T
J Am Soc Nephrol; 2005 Feb; 16(2):408-16. PubMed ID: 15625073
[TBL] [Abstract][Full Text] [Related]
9. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
10. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.
Miyauchi N; Saito A; Karasawa T; Harita Y; Suzuki K; Koike H; Han GD; Shimizu F; Kawachi H
J Am Soc Nephrol; 2006 Oct; 17(10):2748-59. PubMed ID: 16943307
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.
Macconi D; Bonomelli M; Benigni A; Plati T; Sangalli F; Longaretti L; Conti S; Kawachi H; Hill P; Remuzzi G; Remuzzi A
Am J Pathol; 2006 Jan; 168(1):42-54. PubMed ID: 16400008
[TBL] [Abstract][Full Text] [Related]
12. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
Andrews PM
Lab Invest; 1977 Feb; 36(2):183-97. PubMed ID: 839733
[TBL] [Abstract][Full Text] [Related]
13. Urinary kallikrein in experimental renal disease.
Glasser RJ; Michael AF
Lab Invest; 1976 Jun; 34(6):616-22. PubMed ID: 933467
[TBL] [Abstract][Full Text] [Related]
14. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?
Torras J; Herrero-Fresneda I; Gulias O; Flaquer M; Vidal A; Cruzado JM; Lloberas N; Franquesa Ml; Grinyó JM
Nephrol Dial Transplant; 2009 Dec; 24(12):3632-40. PubMed ID: 19671594
[TBL] [Abstract][Full Text] [Related]
16. Novel expression of sodium/myo-inositol co-transporter in podocytes in puromycin aminonucleoside nephrosis.
Watanabe Y; Kobayashi T; Yaoita E; Kawachi H; Yamauchi A; Inoue T; Shimizu F; Yoshida Y; El-Shemi AG; Okada H; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Apr; 19(4):817-22. PubMed ID: 15031335
[TBL] [Abstract][Full Text] [Related]
17. Urinary detection of podocyte injury.
Camici M
Biomed Pharmacother; 2007 Jun; 61(5):245-9. PubMed ID: 17532599
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.
Kuhlmann A; Haas CS; Gross ML; Reulbach U; Holzinger M; Schwarz U; Ritz E; Amann K
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F526-33. PubMed ID: 14600034
[TBL] [Abstract][Full Text] [Related]
19. Effects of podocyte injury on glomerular development.
Ma J; Rossini M; Yang HC; Zuo Y; Fogo AB; Ichikawa I
Pediatr Res; 2007 Oct; 62(4):417-21. PubMed ID: 17667850
[TBL] [Abstract][Full Text] [Related]
20. The role of podocytes dysfunction in chronic glomerulonephritis progression.
Chebotareva NV; Bobkova IN; Lysenko LV
Ter Arkh; 2018 Jun; 90(6):92-97. PubMed ID: 30701911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
